Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS : revenue, balance sheet and financial ratios

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is a French company founded 8 years ago, specialized in the sector Gestion de fonds. Based in CERGY (95800), this company of category PME shows in 2022 a revenue of 276 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS (SIREN 832900716)
Kennzahl 2022 2020 2019 2018 2017
Umsatz 275 899 € N/C N/C N/C N/C
Nettoergebnis -99 122 € -28 772 € -18 570 € -121 723 € -30 782 €
EBITDA -24 142 € -6 962 € -31 732 € -5 785 € -13 585 €
Nettomarge -35.9% N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2022, NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS achieves revenue of 276 k€. After deducting consumption (0 €), gross margin stands at 276 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -24 k€, representing -8.8% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -99 k€ (-35.9% of revenue), which will impact equity.

Umsatz (2022) ?
Umsatz
Definition
Gesamtbetrag der Verkäufe von Waren und Dienstleistungen des Unternehmens.
Formel
Warenverkäufe + Verkaufte Produktion

275 899 €

Bruttomarge (2022) ?
Bruttomarge
Definition
Differenz zwischen Umsatz und Wareneinsatz.
Formel
Umsatz - Wareneinsatz

275 899 €

EBITDA (2022) ?
EBITDA (Betriebsergebnis vor Abschreibungen)
Definition
Ressource générée par l'activité courante, avant amortissements et charges financières.
Formel
Wertschöpfung - Personalkosten - Steuern
Interpretation
Positiv = rentable Tätigkeit

-24 142 €

EBIT (2022) ?
EBIT (Betriebsergebnis)
Definition
Betriebsergebnis, einschließlich Abschreibungen und Rückstellungen.
Formel
EBITDA - Abschreibungen und Rückstellungen + Auflösungen

-20 372 €

Nettoergebnis (2022) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

-99 122 €

EBITDA-Marge (2022) ?
EBITDA-Marge
Definition
Misst die operative Rentabilität des Unternehmens.
Formel
(EBE / CA) x 100
Interpretation
> 10% : Gute Rentabilität
5-10% : Durchschnitt
< 5% : Faible

-8.8%

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 176%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2022) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

175.54%

Finanzielle Autonomie (2022) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

35.861%

Cashflow / Umsatz (2022) ?
Cashflow / Umsatz
Definition
Capacité d'autofinancement rapportée au chiffre d'affaires.
Formel
(CAF / CA) x 100
Interpretation
Je höher das Verhältnis, desto mehr Liquidität generiert das Unternehmen

-37.269%

Rückzahlungsfähigkeit (2022) ?
Rückzahlungsfähigkeit
Definition
Anzahl der Jahre zur Schuldenrückzahlung mit dem Cashflow.
Formel
Dettes financières / CAF
Interpretation
< 3 Jahre : Ausgezeichnet
3-5 Jahre : Angemessen
> 5 Jahre : Attention

-49.538

Entwicklung der Solvenzkennzahlen
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Positionnement sectoriel

Debt ratio
175.54 2022
2019
2020
2022
Q1: 0.01
Méd: 15.76
Q3: 126.84
Average

In 2022, the debt ratio of NISSHA MEDICAL TECHNOLOGI... (175.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.86% 2022
2019
2020
2022
Q1: 12.07%
Méd: 51.86%
Q3: 87.99%
Average

In 2022, the financial autonomy of NISSHA MEDICAL TECHNOLOGI... (35.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-49.54 years 2022
2019
2020
2022
Q1: -0.05 years
Méd: 0.0 years
Q3: 3.2 years
Excellent

In 2022, the repayment capacity of NISSHA MEDICAL TECHNOLOGI... (-49.54) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 1010.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2022) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

1010.697

Zinsdeckung (2022) ?
Zinsdeckung
Definition
Fähigkeit, Zinsaufwendungen mit dem Betriebsergebnis zu decken.
Formel
EBIT / Zinsaufwendungen
Interpretation
> 3 : Komfortabel
1.5-3 : Acceptable
< 1.5 : Risiko

-385.399

Entwicklung der Liquiditätskennzahlen
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Positionnement sectoriel

Liquidity ratio
1010.7 2022
2019
2020
2022
Q1: 96.31
Méd: 393.46
Q3: 2443.4
Good +24 pts über 3 Jahre

In 2022, the liquidity ratio of NISSHA MEDICAL TECHNOLOGI... (1010.70) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-385.4x 2022
2019
2020
2022
Q1: -46.6x
Méd: 0.0x
Q3: 0.0x
Average

In 2022, the interest coverage of NISSHA MEDICAL TECHNOLOGI... (-385.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 60 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 245 days. Excellent situation: suppliers finance 185 days of the operating cycle (retail model). Overall, WCR represents 1185 days of revenue, i.e. 908 k€ to permanently finance.

Operatives Working Capital (2022) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

908 290 €

Kundenforderungen (2022) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

60 j

Lieferantenverbindlichkeiten (2022) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

245 j

Lagerumschlag (2022) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Working Capital in Umsatztagen (2022) ?
Working Capital in Umsatztagen
Definition
Drückt den Betriebskapitalbedarf in Umsatztagen aus.
Formel
(BFR exploitation / CA) x 360
Interpretation
Je weniger Tage, desto besser das Working Capital Management

1185 j

Entwicklung des Working Capital und der Zahlungsfristen
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Positionnement de NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS dans son secteur

Vergleich mit der Branche Gestion de fonds

Bewertungsschätzung

Based on 109 transactions of similar company sales in 2022, the value of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is estimated at 155 569 € (range 87 090€ - 341 835€). The price/revenue ratio is 0.56x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
109 transactions
87k€ 155k€ 341k€
155 569 € Range: 87 090€ - 341 835€
NAF 5 année 2022

Valuation method used

Revenue Multiple
275 899 € × 0.56x = 155 569 €
Range: 87 090€ - 341 836€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 109 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Gestion de fonds

Frequently asked questions about NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

What is the revenue of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The revenue of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS in 2022 is 276 k€.

Is NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS profitable?

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS recorded a net loss in 2022.

Where is the headquarters of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The headquarters of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is located in CERGY (95800), in the department Val-d'Oise.

Where to find the tax return of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The tax return of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS operate?

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.